Intrinsic Value of S&P & Nasdaq Contact Us

Vifor Pharma AG GNHAY OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CH • USD

SharesGrow Score
69/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — GNHAY

Vifor Pharma AG (GNHAY) and trades at $38.39. The 52-week range is 31.18-38.385.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 46.8, Earnings Per Share (EPS) of $0.82, annual revenue of $1.82B.

The stock has a beta of 0.00, a last dividend of $2.0288, operates in the Healthcare sector.

Trading Data
Current Price$38.39
52-Week Range31.18-38.385
Volume200
Avg Volume (30D)13
Beta (1Y)0.00
Last Dividend$2.0288
Company
IPO Date2021-01-08
Employees2,200
CEOShah Abbas Hussain BSc
CountryCH
ExchangeOther OTC
CurrencyUSD
ISINUS92674R1023
CUSIP363378100
Income (Latest Year)
Revenue$1.82B
Gross Profit$1.15B
EBITDA$519.6M
Operating Income$199.7M
Net Income$265.4M
EPS$0.82
EPS Diluted$0.82
Shares Outstanding$325.14M
Balance Sheet (Latest Year)
Total Assets$5.1B
Current Assets$1.88B
Cash & ST Investments$993.6M
Total Liabilities$1.13B
Total Debt$587.1M
Net Debt$-406.5M
Total Equity$3.49B
Debt / Equity0.17
Valuation Ratios
P/E Ratio46.8
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message